- Algernon is a Canada-based pharmaceutical company that seeks to repurpose previously approved drugs.
- The company's lead candidate is called Ifenprodil, which they are exploring to treat pulmonary fibrosis and chronic cough.
- Recently, they also announced pre-clinical data using the hallucinogenic DMT, better known as "the spirit molecule."
- Despite their novel approach, Algernon is struggling to maintain financial viability and needs to develop a partnership to increase its chances of long-term success.
For further details see:
Algernon Pharmaceuticals: A Microcap With A Novel Approach To Drug Development